Dedeene, Lieselot http://orcid.org/0000-0003-0545-8072
Van Schoor, Evelien
Ospitalieri, Simona
Ronisz, Alicja
Weishaupt, Jochen H.
Otto, Markus
Ludolph, Albert C.
Scheuerle, Angelika
Vandenberghe, Rik
Van Damme, Philip
Poesen, Koen
Thal, Dietmar Rudolf http://orcid.org/0000-0002-1036-1075
Funding for this research was provided by:
Fonds Wetenschappelijk Onderzoek (1165119N, 1S46219N, senior clinical investigatorship, FWO-Odysseus grant No. G0F8516N, FWO-Odysseus grant No. G0F8516N)
E. von Behring Chair for Neuromuscular and Neurodegenerative Disorders
ALS Liga Belgium
Onderzoeksraad, KU Leuven (ALS funds ‘Een hart voor ALS’, ‘Laeversfonds voor ALS onderzoek', ‘Valéry Perrier Race against ALS Fund’, C14-17-107, C14-17-107)
Vlaamse Impulsfinanciering voor Netwerken voor Dementie Onderzoek (VIND, IWT 135043, VIND, IWT 135043)
Mady Browaeys Fund for Research into Frontotemporal degeneration
German Federal Ministry of Education and Research (FTLDc 01GI1007A, MND-Net 01GM1103A)
German Research Foundation/DFG (SFB1279)
Fondation Thierry Latran
EU Joint Programme-Neurodegenerative Diseases networks Genfi-Prox
Article History
Received: 16 July 2020
Revised: 19 August 2020
Accepted: 19 August 2020
First Online: 30 August 2020
Conflict of interest
: MO gave scientific advice for Roche (Switzerland), Biogen (USA) and Axon. ACL serves on the Advisory Board of Roche Pharma (Switzerland) and Biogen (USA), and on the data and safety monitoring board of Zeneus pharma (UK). ACL received consulting fees from AB-Science (FRA), Desitin (UK), Novartis (Switzerland) and Teva (ISR). RV’s institution has a clinical trial agreement (RV as PI) with AbbVie (USA), Biogen (USA), Genentech (USA), Novartis (Switzerland), and Roche (Switzerland). PVD participated in advisory board meetings for Genzyme (USA), Pfizer (USA), Biogen (USA), Cytokinetics (USA), Mitsubishi Tanabe (Japan), CSL Behring (USA) and Alexion Pharmaceuticals (USA). DRT received speaker honorary from Novartis Pharma AG (Switzerland) and Biogen (USA), travel reimbursement from GE-Healthcare (UK) and UCB (BE), and collaborated with Novartis Pharma AG (Switzerland), Probiodrug (Germany), GE-Healthcare (UK), and Janssen Pharmaceutical Companies (Belgium).